Progression free survival (PFS) in alemtuzumab based RIC allogeneic transplantation for myeloma is improved with use of pre-emptive DLI (pDLI)

K Ramasamy, S Mahmood, L Pearce, Z Lim, D Ladon, A Pagliuca, S Devereux, G J Mufti, S Schey

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)3034
Number of pages1
JournalBlood
Volume110
Issue number11
Publication statusPublished - 2007
Event49th Annual Meeting of the American-Society-of-Hematology - Atlanta, GA
Duration: 1 Jan 2007 → …

Cite this